G2E3 and inflammatory bowel disease: Our findings indicate that the expression of G2E3 is reduced in patients with IBD, whereas that of G2E3 is increased in patients with ALS, and the expression of G2E3 in the two diseases was positively correlated with the expression of SCFD1, which could simultaneously exert its functions.